Ablynx « Terug naar discussie overzicht

Wat na ABLYNX welke aandeln kunnen veel groeien om welke redenen.

3 Posts

Omlaag ↓

[verwijderd] 30 januari 2018 14:27

Wat na Ablynx welke aandelen hebben kans om veel t groeien en om welke redenen

[verwijderd] 1 februari 2018 11:34

Merus, bispecifieke antibodies zijn de toekomst. bivoorbeeld: Basel, June 28, 2016 - Today Novartis announced that it has entered into a collaboration and licensing agreement with Xencor for the development of bispecific antibodies for treating cancer. The agreement is the latest in a series of acquisitions and strategic collaborations between Novartis and biotech companies that have helped bolster its deep and diverse immuno-oncology pipeline.

Traditional monoclonal antibodies target and bind to a single antigen. Bispecific antibodies are engineered to recognize and target two different antigens, which makes them potentially more effective in targeting complex diseases. A T-cell engaging bispecific antibody is able to bind an antigen on a tumor cell with one arm and engage T-cells capable of their destruction with the other.

[verwijderd] 6 maart 2018 12:47

Op zoek naar overnamekandidaten in de biotech zoals Ablynx of Tigenix.
Conatus pharmaceuticals lijkt een overnameprooi te gaan worden beurskrant.com/2018/03/06/stijgingspo...

3 Posts

Aantal posts per pagina: 20 50 100 | Omhoog ↑

Meedoen aan de discussie?

Word nu gratis lid of log in met uw e-mailadres en wachtwoord.

Direct naar Forum

Markt vandaag

AEX 911,91 +1,32 +0,14% 18:05


Germany40^	18.721,30	-0,27%
BEL 20	3.980,58	-0,82%
Europe50^	5.072,91	-0,24%
US30^	39.441,50	-0,17%
Nasd100^	18.197,40	+0,22%
US500^	5.220,42	-0,02%
Japan225^	38.161,70	-0,07%
Gold spot	2.335,78	-1,06%
EUR/USD	1,0789	+0,16%
WTI	78,71	+0,55%